No association between dopamine D2 and D4 receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors

Psychiatry Research

Volumn 104, Issue 3, 2001, Pages 195-203

  Serretti, Alessandro ^a   Zanardi, Raffaella ^a   Cusin, Cristina ^a   Rossini, David ^a   Lilli, Roberta ^a   Lorenzi, Cristina ^a   Lattuada, Enrico ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antidepressant treatment; Fluvoxamine; Mood disorders; Paroxetine; Pharmacogenetics; Pindolol

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; FLUVOXAMINE; PAROXETINE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DNA DETERMINATION; DRUG BLOOD LEVEL; EXON; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE;

DEPRESSIVE DISORDER, MAJOR; EXONS; FEMALE; FLUVOXAMINE; GENE EXPRESSION; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PAROXETINE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SEROTONIN UPTAKE INHIBITORS;

EID: 0035976689     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(01)00324-9     Document Type: Article

References (58)

1. Effect of antidepressant drugs on dopamine D-1 and D-2 receptor expression and dopamine release in the nucleus accumbens of the rat
2. Association of dopamine D2 receptor molecular variant with schizophrenia
3. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants
4. Response to clozapine in acute mania is more rapid than that of chlorpromazine
5. Scales for assessment of diagnosis and severity of mental disorders
6. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression
7. Clozapine for treatment-refractory mania
8. 11C-benztropine in primates
9. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects
10. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis
11. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families
12. Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH Treatment of Depression Collaborative Research Program dataset
13. Serotonin inhibits acetylcholine release from rat striatum slices: Evidence for a presynaptic receptor-mediated effect
14. The human D2 dopamine receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP
15. Development of a rating scale for primary depressive illness
16. Effect of antidepressants on striatal and accumbens extracellular dopamine levels
17. A structural polymorphism of human dopamine D2 receptor, D2(Ser311→Cys)
18. Dopamine-related genes and their relationships to monoamine metabolites in CSF
19. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine
20. Serotonin-dopamine interaction and its relevance to schizophrenia
21. Serotonin transporter gene polymorphism and antidepressant response
22. 123I]IBZM SPECT
23. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia
24. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies
25. Best estimate of lifetime psychiatric diagnosis: A methodological study
26. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor
27. Analysis of the D4 dopamine receptor gene variant in an Italian schizophrenia kindred
28. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist
29. Linkage studies between affective disorder and dopamine D2, D3, and D4 receptor gene loci in four Japanese pedigrees
30. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors
31. Dopamine D2 receptor molecular variant and schizophrenia
32. Pharmacogenetic response to antidepressants in a multicase family with affective disorder
33. Association study between bipolar disorder and candidate genes involved in dopamine-serotonin metabolism and GABAergic neurotransmission: A preliminary report
34. A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample
35. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum
36. Serotonin dysfunction disorders: A behavioral neurochemistry perspective
37. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression
38. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: A comparison with citalopram
39. Linkage strategies for genetically complex traits: I. Multilocus models
40. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine
41. Dopamine receptor D2 ser/cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses
42. Patterns of symptom improvement during antidepressant treatment of delusional depression
43. Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia
44. Dopamine receptor D2 Ser Cys311 variant associated with disorganized symptomatology of schizophrenia
45. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
46. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
47. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes
48. Increase of extracellurar dopamine in the prefrontal cortex: A trait of drugs with antidepressant potential?
49. PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties
50. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
51. Multiple dopamine D4 receptor variants in the human population
52. How long should pindolol be associated with paroxetine to improve the antidepressant response?
53. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene
54. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression
55. Is clozapine a mood stabilizer?